Colossal Biosciences
A de-extinction biotechnology company aiming to revive extinct species.
Technology stack
detected 2026-05-24What does Colossal Biosciences do?
Colossal Biosciences is a biotechnology company focused on de-extinction, with the goal of bringing back extinct species like the woolly mammoth, the dire wolf, the South Island giant moa, and the dodo. They utilize genetic engineering and advanced reproductive technologies, including artificial eggshells, to achieve their ambitious conservation and scientific objectives. The company also aims to apply its technologies to conservation efforts for endangered species.
How much funding has Colossal Biosciences raised?
Colossal Biosciences has raised a total of $225M in funding. The most recent round on record is Series B.
Where is Colossal Biosciences headquartered?
Colossal Biosciences is headquartered in Dallas, Texas, USA.
When was Colossal Biosciences founded?
Colossal Biosciences was founded in 2021.
What industry does Colossal Biosciences operate in?
Colossal Biosciences operates in Biotechnology, Genetics, Conservation, De-extinction, Biotech, Genomics.